IL6 and colitis: The results showed that ARS treatment notably downregulated the mRNA (Figures 6A–C) and protein (Figures 6D–F) expression of IL-1β, IL-6, TNF-α, and the protein ratio of p-p65/p65 and p-IκBα/IκBα (Figures 6G,H) in colon tissues in colitis mice (p < 0.01).